If you or someone you know struggles with depression, new treatments are a beacon of hope. You'll learn how a compound from 'magic mushrooms' is showing remarkable promise in rewiring the brain to alleviate severe depression.
The FDA has granted 'Breakthrough Therapy' status to psilocybin, the psychoactive compound in 'magic mushrooms,' for treating severe depression. This designation speeds up development and review for drugs that show substantial improvement over available therapies.
This isn't just a niche interest; major institutions like Johns Hopkins and NYU are conducting rigorous clinical trials.